// App-Quantinova.ai

TCT-330 : Multi-Center Evaluation of a Novel 120 μm Novolimus-Eluting, Fully Bioresorbable Coronary Scaffold: First Report of 6-month Imaging and 12-Month Clinical Results

Researchers

Presenter

  • Alexandre Abizaid

Principal Investigators

  • Mathias Vrolix

  • J. Ribamar Costa Jr.

  • Daniel Chamie

  • Andrea Abizaid

  • Juliana Castro

  • Vinayak Bhat

  • Lynn Morrison

  • Sara Toyloy

  • Stefan Verheye

Medical Centers

  • Elixir Medical, sunnyvale, California, United States

  • St Jan Zikenhuis ZOL, Genk, Belgium

  • CRC, São Paulo, São Paulo, Brazil

  • Cardiovascular Center ZNA Middelheim, Antwerp, Belgium

  • Instituto Dante Pazzanese de Cardiologia, São Paulo, São Paulo, Brazil

Locations

  • United States

  • Brazil

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Genetic Disorder

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

Disease

  • Coronary artery lesions

  • Venous thrombosis

Biomarkers

  • Serine/threonine-protein kinase mTOR

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Single Arm

  • Multicenteric

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved